VILL
Villin-like protein
Also known as: VILL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15195
- Gene
- VILL
- Ensembl
- ENSG00000136059
- Chromosome
- 3
- Canonical length
- 856 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the villin/gelsolin family. It contains 6 gelsolin-like repeats and a headpiece domain. It may play a role in actin-bundling. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
856 residues, UniProt reviewed canonical sequence.
>O15195|VILL
1 MDISKGLPGM QGGLHIWISE NRKMVPVPEG AYGNFFEEHC YVILHVPQSP KATQGASSDL
61 HYWVGKQAGA EAQGAAEAFQ QRLQDELGGQ TVLHREAQGH ESDCFCSYFR PGIIYRKGGL
121 ASDLKHVETN LFNIQRLLHI KGRKHVSATE VELSWNSFNK GDIFLLDLGK MMIQWNGPKT
181 SISEKARGLA LTYSLRDRER GGGRAQIGVV DDEAKAPDLM QIMEAVLGRR VGSLRAATPS
241 KDINQLQKAN VRLYHVYEKG KDLVVLELAT PPLTQDLLQE EDFYILDQGG FKIYVWQGRM
301 SSLQERKAAF SRAVGFIQAK GYPTYTNVEV VNDGAESAAF KQLFRTWSEK RRRNQKLGGR
361 DKSIHVKLDV GKLHTQPKLA AQLRMVDDGS GKVEVWCIQD LHRQPVDPKR HGQLCAGNCY
421 LVLYTYQRLG RVQYILYLWQ GHQATADEIE ALNSNAEELD VMYGGVLVQE HVTMGSEPPH
481 FLAIFQGQLV IFQERAGHHG KGQSASTTRL FQVQGTDSHN TRTMEVPARA SSLNSSDIFL
541 LVTASVCYLW FGKGCNGDQR EMARVVVTVI SRKNEETVLE GQEPPHFWEA LGGRAPYPSN
601 KRLPEEVPSF QPRLFECSSH MGCLVLAEVG FFSQEDLDKY DIMLLDTWQE IFLWLGEAAS
661 EWKEAVAWGQ EYLKTHPAGR SPATPIVLVK QGHEPPTFIG WFFTWDPYKW TSHPSHKEVV
721 DGSPAAASTI SEITAEVNNL RLSRWPGNGR AGAVALQALK GSQDSSENDL VRSPKSAGSR
781 TSSSVSSTSA TINGGLRREQ LMHQAVEDLP EGVDPARREF YLSDSDFQDI FGKSKEEFYS
841 MATWRQRQEK KQLGFFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VILL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 82 nTPM
Expression across tissuesHPA
Tissue
- stomach: 82 nTPM
- small intestine: 52 nTPM
- duodenum: 51 nTPM
- colon: 36 nTPM
- rectum: 21 nTPM
- prostate: 15 nTPM
Single-cell type
- foveolar cells: 432 nCPM
- colonocytes: 188 nCPM
- enterocytes: 180 nCPM
- goblet cells: 113 nCPM
- retinal pigment epithelial cells: 102 nCPM
- respiratory secretory cells: 78 nCPM
Immune cell
- MAIT T-cell: 7.3 nTPM
- gdT-cell: 6.8 nTPM
- T-reg: 5.8 nTPM
- naive CD4 T-cell: 5.6 nTPM
- naive B-cell: 4.6 nTPM
- memory CD4 T-cell: 4.4 nTPM
Brain region
- basal ganglia: 8.4 nTPM
- amygdala: 8 nTPM
- hippocampal formation: 8 nTPM
- midbrain: 7.6 nTPM
- medulla oblongata: 7.1 nTPM
- hypothalamus: 7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- actin filament binding
- phosphatidylinositol-4,5-bisphosphate binding
- structural constituent of cytoskeleton
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VILL as an antibody target. Whether an autoantibody or antibody against VILL could matter depends on whether native VILL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VILL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VILL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...